Dr. Lei Zheng is Professor of Oncology and Surgery in the Gastrointestinal Oncology Program at the Johns Hopkins University School of Medicine. He is Director of the Pancreatic Cancer Precision Medicine Center of Excellence at Johns Hopkins and Director of the Multidisciplinary Hepato-Panreato-Biliary Research Laboratory. His clinical work is focused on multidisciplinary management for pancreatic cancer, bile duct cancer, liver metastases, and gastric cancer. In addition, he is a lead researcher in the group of Johns Hopkins Cancer Center’s physician scientists.
Since 2013, he has published over 150 peer-reviewed papers and given more than 40 plenary and keynote speeches in national and international symposia. He is the founding Editor-in-Chief of Annals of Pancreatic Cancer. In 2021, he was elected into the American Society of Clinical Oncology. He served or is serving as a Councilor for Pancreatic Disorders (PAN) section of the American Gastroenterological Association Institute Council, a Member of the American Society of Clinical Oncology Grant Selection Committee and Education Committee, and a Member of the American Association for Cancer Research (AACR) Program Committee. He is also chairing the China Regional Advisory Group for the AACR International Affair Committee. He is Vice Chair of the World Association of Chinese Oncologists, is the Secretory General of the Committee of Oversea Experts of the Chinese Society of Clinical Oncology (CSCO), and is the Immediate Past President of the Chinese American Hematologist and Oncologist Network (CAHON).